Medical & Biological Laboratories Company Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medical & Biological Laboratories Company Limited with three other
pharmaceutical manufacturers in Asia:
CellSource Co Ltd
sales of 1.61 billion Japanese Yen [US$14.67 million]
of which 74%
was Regenerative Medicine Related Business),
Thyrocare Technologies Ltd
(4.03 billion Indian Rupees [US$56.29 million]
of which 91%
was Diagnostic Testing Services), and
Malaysian Genomics Resource Centre Berhad
based in Malaysia
(27.73 million Malaysian Ringgits [US$6.67 million]
Medical & Biological Laboratories Company Limited reported sales of ¥8.18 billion (US$74.46 million)
March of 2019.
increase of 15.7%
versus 2018, when the company's sales were ¥7.07 billion.
Sales of Reagent Business saw an increase
15.8% in 2019, from
¥7.01 billion to ¥8.12 billion.